Professor Ilshat Gaisin
Izhevsk State Medical Academy, Izhevsk (Russian Federation)
Mothers with post-partum hypertension and kidney damage after pre-eclampsia should receive ACE inhibitors rather than methyldopa
Event: ESC Congress 2020
Topic: Cardiovascular Disease in Women
Session: Cardiovascular Disease in Special Populations ePosters
Magnesium orotate for the treatment of heart failure in pregnant patients with unoperated atrial or ventricular septal defect
Event: Heart Failure 2019
Topic: Cardiovascular Pharmacotherapy, Other
Session: Pharmacology and Pharmacotherapy
Magnesium orotate is a promising therapy for not closed atrial or ventricular septal defect in pregnant patients
Event: EuroPrevent 2018
Topic: Cardiovascular Disease in Special Populations, Other
Session: Cardiovascular disease in special populations
Magnesium orotate for the treatment of preexisting hypertension and nondifferentiable connective tissue dysplasia in pregnant women
Event: EuroPrevent 2018
Topic: Cardiovascular Disease in Special Populations, Other
Session: Cardiovascular disease in special populations
Indapamide sustained-release is safe and effective in the treatment of post partial hypertension: results from an observational, case-control 12-month study
Event: EuroPrevent 2018
Topic: Cardiovascular Disease in Special Populations, Other
Session: Cardiovascular disease in special populations
Magnesium orotate improves symptoms, exercise capacity and quality of life in patients with valve prosthesis: results from a randomized, open-label, case-control 2-year study
Event: ESC Congress 2016
Topic: Pharmacologic therapy
Session: Novel pharmacological therapy in chronic heart failure
Magnesium orotate improves health-related quality of life after surgical valve replacement
Event: HEART FAILURE 2016
Topic: Valvular heart disease
Session: Valvular heart disease (diagnosis, management and interventional therapies)
Magnesium orotate may be a new promising therapy of heart failure in operated valvular heart disease
Event: HEART FAILURE 2016
Topic: Valvular heart disease
Session: Valvular heart disease(diagnosis, management and interventional therapies)
ESC 365 is supported by
